In the last 12 months, insiders at Senti Biosciences, Inc. ($SNTI) filed 59 transactions with the SEC: 2 open-market purchases totaling $0 and 4 sales totaling $24,413. Net insider sentiment: net selling.
Senti Biosciences, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Rajangam Kanya (Pres. & Chief Med. & Dev. Off.) — 10 transactions totaling $84,824
- Lu Timothy K (CEO) — 4 transactions totaling $18,339
- KNOBELMAN DEBORAH (Chief Financial Officer) — 3 transactions totaling $0
- Cross John Harry III (Chief Financial Officer) — 1 transaction totaling $0
- Lu Timothy K (CEO and Interim PFO and PAO) — 2 transactions totaling $0
View all SEC Filings for Senti Biosciences, Inc. (SNTI).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Lu Timothy K | CEO | F | Common Stock | 80666 | $0.00 | 745,261.0000 | 26,290,838 | 9.77% | 0.31% |
| March 9, 2026 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | F | Common Stock | 10757 | $0.00 | 74,843.0000 | 26,290,838 | 12.57% | 0.04% |
| Feb. 2, 2026 | Lu Timothy K | CEO | F | Common Stock | 4191 | $0.00 | 825,927.0000 | 26,290,838 | 0.50% | 0.02% |
| Feb. 2, 2026 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | F | Common Stock | 1384 | $0.00 | 85,600.0000 | 26,290,838 | 1.59% | 0.01% |
| July 18, 2025 | Baum Bryan Daniel | Director | A | Stock Option (Right to Buy) | 43900 | $0.00 | 43,900.0000 | 26,160,206 | 9999.99% | 0.17% |
| June 25, 2025 | Tang Donald F | Not found | A | Stock Option (Right to Buy) | 21950 | $0.00 | 21,950.0000 | 26,004,366 | 9999.99% | 0.08% |
| June 25, 2025 | Mathers Edward T | Not found | A | Stock Option (Right to Buy) | 21950 | $0.00 | 21,950.0000 | 26,004,366 | 9999.99% | 0.08% |
| June 25, 2025 | Collins James J. | Not found | A | Stock Option (Right to Buy) | 21950 | $0.00 | 21,950.0000 | 26,004,366 | 9999.99% | 0.08% |
| June 25, 2025 | Hsiung Feng | Not found | A | Stock Option (Right to Buy) | 21950 | $0.00 | 21,950.0000 | 26,004,366 | 9999.99% | 0.08% |
| June 25, 2025 | Schulz Fran | Not found | A | Stock Option (Right to Buy) | 21950 | $0.00 | 21,950.0000 | 26,004,366 | 9999.99% | 0.08% |
| June 25, 2025 | COOPERSTONE BRENDA | Not found | A | Stock Option (Right to Buy) | 21950 | $0.00 | 21,950.0000 | 26,004,366 | 9999.99% | 0.08% |
| March 10, 2025 | Celadon Partners SPV 24 | TenPercentOwner | C | Series A Convertible Preferred Stock | 9777 | $0.00 | 0.0000 | 4,829,035 | 100.00% | 0.20% |
| March 10, 2025 | Celadon Partners SPV 24 | TenPercentOwner | C | Common Stock | 9777000 | $0.00 | 9,777,000.0000 | 4,829,035 | 9999.99% | 100.00% |
| March 10, 2025 | BAYER HEALTHCARE LLC | TenPercentOwner | C | Common Stock | 2222000 | $0.00 | 2,809,848.0000 | 4,829,035 | 377.99% | 46.01% |
| March 10, 2025 | BAYER HEALTHCARE LLC | TenPercentOwner | C | Series A Convertible Preferred Stock | 2222 | $0.00 | 0.0000 | 4,829,035 | 100.00% | 0.05% |
| March 10, 2025 | New Enterprise Associates 15, L.P. | Not found | C | Common Stock | 3333000 | $0.00 | 3,775,615.0000 | 4,829,035 | 753.02% | 69.02% |
| March 10, 2025 | New Enterprise Associates 15, L.P. | Not found | C | Series A Convertible Preferred Stock | 3333 | $0.00 | 0.0000 | 4,829,035 | 100.00% | 0.07% |
| March 7, 2025 | Collins James J. | Director | A | Stock Option (Right to Buy) | 43900 | $0.00 | 43,900.0000 | 4,829,035 | 9999.99% | 0.91% |
| March 7, 2025 | Tang Donald F | Director | A | Stock Option (Right to Buy) | 43900 | $0.00 | 43,900.0000 | 4,829,035 | 9999.99% | 0.91% |
| March 7, 2025 | COOPERSTONE BRENDA | Director | A | Stock Option (Right to Buy) | 43900 | $0.00 | 43,900.0000 | 4,829,035 | 9999.99% | 0.91% |
| March 7, 2025 | Hsiung Feng | Director | A | Stock Option (Right to Buy) | 43900 | $0.00 | 43,900.0000 | 4,829,035 | 9999.99% | 0.91% |
| March 7, 2025 | Cross John Harry III | Chief Financial Officer | A | Stock Option (Right to Buy) | 174200 | $0.00 | 174,200.0000 | 4,829,035 | 9999.99% | 3.61% |
| March 10, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | C | Common Stock | 33000 | $2.25 | 119,984.0000 | 4,829,035 | 37.94% | 0.68% |
| March 7, 2025 | Mathers Edward T | Not found | A | Stock Option (Right to Buy) | 43900 | $0.00 | 43,900.0000 | 4,829,035 | 9999.99% | 0.91% |
| March 10, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | C | Series A Convertible Preferred Stock | 33 | $2250.00 | 0.0000 | 4,829,035 | 100.00% | 0.00% |
| March 7, 2025 | Schulz Fran | Director | A | Stock Option (Right to Buy) | 43900 | $0.00 | 43,900.0000 | 4,829,035 | 9999.99% | 0.91% |
| March 7, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | A | Common Stock | 78363 | $0.00 | 86,984.0000 | 4,829,035 | 908.98% | 1.62% |
| March 6, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | A | Stock Option (Right to Buy) | 235088 | $0.00 | 235,088.0000 | 4,829,035 | 9999.99% | 4.87% |
| March 7, 2025 | Lu Timothy K | CEO and Interim PFO and PAO | A | Common Stock | 642358 | $0.00 | 830,118.0000 | 4,829,035 | 342.12% | 13.30% |
| March 6, 2025 | Lu Timothy K | CEO and Interim PFO and PAO | A | Stock Option (Right to Buy) | 1927073 | $0.00 | 1,927,073.0000 | 4,829,035 | 9999.99% | 39.91% |
| Feb. 6, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | S | Common Stock | 182 | $4.37 | 8,621.0000 | 4,829,035 | 2.07% | 0.00% |
| Feb. 4, 2025 | Lu Timothy K | CEO | S | Common Stock | 3922 | $4.07 | 188,305.0000 | 4,829,035 | 2.04% | 0.08% |
| Feb. 6, 2025 | Lu Timothy K | CEO | S | Common Stock | 545 | $4.36 | 187,760.0000 | 4,829,035 | 0.29% | 0.01% |
| Feb. 4, 2025 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | S | Common Stock | 1297 | $4.07 | 8,803.0000 | 4,829,035 | 12.84% | 0.03% |
| Dec. 9, 2024 | BAYER HEALTHCARE LLC | TenPercentOwner | P | Series A Convertible Preferred Stock | 2222 | $0.00 | 2,222.0000 | 4,586,957 | 9999.99% | 0.05% |
| Dec. 9, 2024 | BAYER HEALTHCARE LLC | TenPercentOwner | P | Warrant | 3333000 | $0.00 | 3,330,000.0000 | 4,586,957 | 0.00% | 72.66% |
| Dec. 9, 2024 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | A | Series A Convertible Preferred Stock | 33 | $2250.00 | 33.0000 | 4,586,957 | 9999.99% | 0.00% |
| Dec. 9, 2024 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | A | Common Stock Warrant (right to buy) | 49500 | $0.00 | 49,500.0000 | 4,586,957 | 9999.99% | 1.08% |
| Dec. 9, 2024 | Schulz Fran | Director | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 4,586,957 | 9999.99% | 0.27% |
| Dec. 9, 2024 | Tang Donald F | Director | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 4,586,957 | 9999.99% | 0.27% |
| July 10, 2024 | COOPERSTONE BRENDA | Director | A | Stock Option (Right to Buy) | 62500 | $0.00 | 62,500.0000 | 4,572,432 | 9999.99% | 1.37% |
| July 10, 2024 | Collins James J. | Director | A | Stock Option (Right to Buy) | 62500 | $0.00 | 62,500.0000 | 4,572,432 | 9999.99% | 1.37% |
| July 10, 2024 | Mathers Edward T | Not found | A | Stock Option (Right to Buy) | 62500 | $0.00 | 62,500.0000 | 4,572,432 | 9999.99% | 1.37% |
| July 10, 2024 | Farokhzad Omid | Director | A | Stock Option (Right to Buy) | 62500 | $0.00 | 62,500.0000 | 4,572,432 | 9999.99% | 1.37% |
| Feb. 1, 2024 | KNOBELMAN DEBORAH | Chief Financial Officer | A | Common Stock | 101000 | $0.00 | 131,000.0000 | 4,569,900 | 336.67% | 2.21% |
| Feb. 1, 2024 | KNOBELMAN DEBORAH | Chief Financial Officer | A | Stock Option (Right to Buy) | 152000 | $0.00 | 152,000.0000 | 4,569,900 | 9999.99% | 3.33% |
| Feb. 1, 2024 | Rajangam Kanya | Chief Medical & Devt. Officer | A | Common Stock | 101000 | $0.00 | 101,000.0000 | 4,569,900 | 9999.99% | 2.21% |
| Feb. 1, 2024 | Rajangam Kanya | Chief Medical & Devt. Officer | A | Stock Option (Right to Buy) | 152000 | $0.00 | 152,000.0000 | 4,569,900 | 9999.99% | 3.33% |
| Feb. 1, 2024 | Lu Timothy K | CEO and President | A | Common Stock | 306000 | $0.00 | 1,922,276.0000 | 4,569,900 | 18.93% | 6.70% |
| Feb. 1, 2024 | Lu Timothy K | CEO and President | A | Stock Option (Right to Buy) | 459000 | $0.00 | 459,000.0000 | 4,569,900 | 9999.99% | 10.04% |
| June 16, 2023 | Farokhzad Omid | Director | A | Stock Option (Right to Buy) | 62500 | $0.00 | 62,500.0000 | 4,406,137 | 9999.99% | 1.42% |
| June 16, 2023 | COOPERSTONE BRENDA | Director | A | Stock Option (Right to Buy) | 62500 | $0.00 | 62,500.0000 | 4,406,137 | 9999.99% | 1.42% |
| June 16, 2023 | Collins James J. | Director | A | Stock Option (Right to Buy) | 62500 | $0.00 | 62,500.0000 | 4,406,137 | 9999.99% | 1.42% |
| June 16, 2023 | Berland Susan D | Director | A | Stock Option (Right to Buy) | 62500 | $0.00 | 62,500.0000 | 4,406,137 | 9999.99% | 1.42% |
| June 16, 2023 | Mathers Edward T | Director | A | Stock Option (Right to Buy) | 62500 | $0.00 | 62,500.0000 | 4,406,137 | 9999.99% | 1.42% |
| Feb. 1, 2023 | Lee Philip J | Chief Technology Officer | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 4,406,137 | 9999.99% | 4.43% |
| Feb. 1, 2023 | KNOBELMAN DEBORAH | Chief Financial Officer | A | Stock Option (Right to Buy) | 130000 | $0.00 | 130,000.0000 | 4,406,137 | 9999.99% | 2.95% |
| Feb. 1, 2023 | Rajangam Kanya | Chief Medical & Devt. Officer | A | Stock Option (Right to Buy) | 130000 | $0.00 | 130,000.0000 | 4,406,137 | 9999.99% | 2.95% |
| Feb. 1, 2023 | Lu Timothy K | CEO and President | A | Stock Option (Right to Buy) | 630000 | $0.00 | 630,000.0000 | 4,406,137 | 9999.99% | 14.30% |